Latest Bellevue Group AG Stock Portfolio
$6.15Billion– No. of Holdings #166
Bellevue Group AG Performance:
2024 Q2: -1.59%YTD: 1.75%2023: 1.05%
Performance for 2024 Q2 is -1.59%, and YTD is 1.75%, and 2023 is 1.05%.
About Bellevue Group AG and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, Bellevue Group AG reported an equity portfolio of $6.2 Billions as of 30 Jun, 2024.
The top stock holdings of Bellevue Group AG are IONS, , VRTX. The fund has invested 6.4% of it's portfolio in IONIS PHARMACEUTICALS INC and 4.8% of portfolio in ARGENX SE.
The fund managers got completely rid off SHOCKWAVE MED INC (SWAV), PACIFIC BIOSCIENCES CALIF IN (PACB) and SPDR S&P 500 ETF TR (SPY) stocks. They significantly reduced their stock positions in BIOMARIN PHARMACEUTICAL INC (BMRN), ACCOLADE INC (ACCD) and HUMANA INC (HUM). Bellevue Group AG opened new stock positions in EDGEWISE THERAPEUTICS INC (EWTX), ALTIMMUNE INC (ALT) and WAYSTAR HLDG CORP. The fund showed a lot of confidence in some stocks as they added substantially to ASTRANA HEALTH INC (AMEH), IQVIA HLDGS INC (IQV) and CARDINAL HEALTH INC (CAH).
The top stock holdings of Bellevue Group AG are IONS, , VRTX. The fund has invested 6.4% of it's portfolio in IONIS PHARMACEUTICALS INC and 4.8% of portfolio in ARGENX SE.
The fund managers got completely rid off SHOCKWAVE MED INC (SWAV), PACIFIC BIOSCIENCES CALIF IN (PACB) and SPDR S&P 500 ETF TR (SPY) stocks. They significantly reduced their stock positions in BIOMARIN PHARMACEUTICAL INC (BMRN), ACCOLADE INC (ACCD) and HUMANA INC (HUM). Bellevue Group AG opened new stock positions in EDGEWISE THERAPEUTICS INC (EWTX), ALTIMMUNE INC (ALT) and WAYSTAR HLDG CORP. The fund showed a lot of confidence in some stocks as they added substantially to ASTRANA HEALTH INC (AMEH), IQVIA HLDGS INC (IQV) and CARDINAL HEALTH INC (CAH).
Bellevue Group AG Equity Portfolio Value
Last Reported on: 14 Aug, 2024
Bellevue Group AG Annual Return Estimates Vs S&P 500
Our best estimate is that Bellevue Group AG made a return of -1.59% in the last quarter. In trailing 12 months, it's portfolio return was 1.63%.
New Buys
| Ticker | $ Bought |
|---|---|
| edgewise therapeutics inc | 25,735,000 |
| altimmune inc | 3,990,000 |
| waystar hldg corp | 3,225,000 |
| nike inc | 263,795 |
| kura oncology inc | 205,900 |
| tempus ai inc | 175,000 |
| ultragenyx pharmaceutical in | 164,400 |
| arcutis biotherapeutics inc | 162,750 |
New stocks bought by Bellevue Group AG
Additions
| Ticker | % Inc. |
|---|---|
| astrana health inc | 2,343 |
| iqvia hldgs inc | 1,004 |
| cardinal health inc | 986 |
| resmed inc | 412 |
| mckesson corp | 412 |
| regeneron pharmaceuticals | 356 |
| pfizer inc | 161 |
| annexon inc | 136 |
Additions to existing portfolio by Bellevue Group AG
Reductions
| Ticker | % Reduced |
|---|---|
| biomarin pharmaceutical inc | -83.77 |
| accolade inc | -82.46 |
| humana inc | -79.02 |
| merck & co inc | -75.97 |
| garmin ltd | -62.5 |
| zoetis inc | -60.84 |
| atricure inc | -52.49 |
| insmed inc | -52.3 |
Bellevue Group AG reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| pacific biosciences calif in | -17,220,900 |
| shockwave med inc | -34,447,100 |
| vaneck etf trust | -1,043,460 |
| verve therapeutics inc | -387,776 |
| bristol-myers squibb co | -1,270,930 |
| viridian therapeutics inc | -334,441 |
| biomea fusion inc | -266,110 |
| regenxbio inc | -252,840 |
Bellevue Group AG got rid off the above stocks
Sector Distribution
Bellevue Group AG has about 91.9% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 91.9 |
| Others | 8.1 |
Market Cap. Distribution
Bellevue Group AG has about 55.5% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| LARGE-CAP | 52.3 |
| MID-CAP | 26.6 |
| UNALLOCATED | 8.4 |
| SMALL-CAP | 7.8 |
| MEGA-CAP | 3.2 |
| MICRO-CAP | 1.6 |
Stocks belong to which Index?
About 68.2% of the stocks held by Bellevue Group AG either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| S&P 500 | 44.4 |
| Others | 31.8 |
| RUSSELL 2000 | 23.8 |
Bellevue Group AG Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Bellevue Group AG
Bellevue Group AG has 166 stocks in it's portfolio. About 40% of the portfolio is in top 10 stocks. MGNX proved to be the most loss making stock for the portfolio. ALNY was the most profitable stock for Bellevue Group AG last quarter.
Last Reported on: 14 Aug, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| A | agilent technologies inc | 0.00 | 704 | 91,260 | added | 30.37 | ||
| AAPL | apple inc | 0.01 | 2,200 | 463,364 | unchanged | 0.00 | ||
| ABBV | abbvie inc | 0.12 | 42,204 | 7,238,830 | added | 52.95 | ||
| ABC | cencora inc | 0.33 | 89,329 | 20,125,800 | reduced | -32.07 | ||
| ABT | abbott labs | 2.71 | 1,606,150 | 166,895,000 | added | 11.99 | ||
| ACCD | accolade inc | 0.05 | 842,577 | 3,016,430 | reduced | -82.46 | ||
| ADMA | adma biologics inc | 0.01 | 30,900 | 345,462 | reduced | -24.45 | ||
| AFK | vaneck etf trust | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| AGIO | agios pharmaceuticals inc | 2.72 | 3,879,550 | 167,286,000 | reduced | -3.16 | ||
| ALGN | align technology inc | 0.56 | 143,982 | 34,761,600 | reduced | -7.05 | ||
| ALKS | alkermes plc | 0.01 | 18,000 | 433,800 | reduced | -25.45 | ||
| ALNY | alnylam pharmaceuticals inc | 3.63 | 919,834 | 223,520,000 | added | 0.17 | ||
| ALT | altimmune inc | 0.06 | 600,000 | 3,990,000 | new | |||
| AMEH | astrana health inc | 0.16 | 250,617 | 10,165,000 | added | 2,343 | ||
| AMGN | amgen inc | 0.15 | 29,528 | 9,226,020 | added | 33.38 | ||
| AMRX | amneal pharmaceuticals inc | 0.01 | 62,760 | 398,526 | added | 38.28 | ||
| ANNX | annexon inc | 0.41 | 5,157,290 | 25,270,700 | added | 136 | ||
| APLS | apellis pharmaceuticals inc | 0.28 | 444,404 | 17,047,300 | reduced | -6.23 | ||
| ARQT | arcutis biotherapeutics inc | 0.00 | 17,500 | 162,750 | new | |||
| ARVN | arvinas inc | 1.03 | 2,390,800 | 63,643,100 | unchanged | 0.00 | ||